strong organ
brokerag consult deliv organ growth
manag maintain full year guidanc expect jlt
acquisit drive long-term growth slightli increas
ep maintain pt ew rate
earn expect adjust ep ahead
consensu mse stronger organ growth better margin drove
upsid vs expect organ growth well
forecast op margin deterior yoy ex account chang ahead
expect exclud account chang underli ep grew
yoy ytd organ growth adjust ep growth
within manag full year guidanc organ growth strong
growth adjust ep
brokerag consult produc organ growth brokerag
guy carpent rose marsh consult oliv wyman
jump mercer although level out-performance
guy carpent oliv wyman could temper strong result
add confid top line growth continu model organ growth
expect margin expans adjust oper margin old
account declin yoy due difficult comp consult
manag expect strong margin expans achiev full year margin
expans goal slow margin expans recent year caus investor
concern manag focus strong earn growth rather
certain margin target expect annual margin expans
jlt drive long-term growth manag confid recent
announc acquisit jlt deliv long-term benefit top
bottom line manag expect modest dilut ep neutral
accret estim cash ep accret ex
amort see note think could potenti upsid
cost save faster debt paydown higher share buyback
slightli increas ep
current model reflect jlt acquisit
see ep compound-annual-growth-rate period maintain pt ep
see balanc risk-reward current level
insur properti casualti unit state america
unless otherwis note metric base modelwar
base consensu methodolog
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
exhibit adjust op ep vs consensu ms estim
million except per share data
revenu
incom continu oper
net debt capit
amount sh repurchas estimate
price target base ep slightli histor averag
reflect sustain double-digit ep growth estim ep compound-annual-growth-rate
econom growth improv price expect strong sharehold return
growth margin expans larger share buyback
million except per share data
incom incom tax
incom continu oper
net incom attribut
oper incom adjust net tax
adjust oper incom continu oper
statement flow
net provid oper activ
net use invest activ
net use financ activ
begin period
increas decreas equival
end period
million except per share data
amount share repurchas
chang commiss fee
chang oper margin
total rev
total rev
